Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2024 Jan-Dec:23:15330338241281326.
doi: 10.1177/15330338241281326.

Comparison of Different Head Tilt Angles in Tomotherapy and Volumetric Modulated Arc Therapy for Hippocampal-Avoidance Whole-Brain Radiotherapy

Affiliations
Comparative Study

Comparison of Different Head Tilt Angles in Tomotherapy and Volumetric Modulated Arc Therapy for Hippocampal-Avoidance Whole-Brain Radiotherapy

Yang Li et al. Technol Cancer Res Treat. 2024 Jan-Dec.

Abstract

Purpose: Hippocampal-avoidance whole-brain radiotherapy (HA-WBRT) planning can present challenges. This study examines the influence of head tilt angles on the dosimetric characteristics of target and organs at risk (OARs), aiming to identify the optimal tilt angle that yields optimal dosimetric outcomes using tomotherapy (TOMO).

Methods: Eight patients diagnosed with brain metastases underwent CT scans at five tilt angles: [0°, 10°), [10°, 20°), [20°, 30°), [30°, 40°), and [40°, 45°]. Treatment plans were generated using TOMO and volumetric modulated arc therapy (VMAT). Dosimetric parameters including conformity index (CI), homogeneity index (HI), D2cc, D98%, and Dmean of PTV, as well as Dmax, and Dmean of OARs were analyzed. Furthermore, a comparison was made between the dosimetric parameters of TOMO and VMAT plans. Finally, delivery efficiency of TOMO plans were assessed.

Results: For the PTV, [40°, 45°] tilt angle demonstrated significantly better conformity, homogeneity, lower D2cc, and lower Dmean for the PTV. Regarding the OARs, the [40°, 45°] head tilt angle demonstrated significantly lower Dmax and Dmean in hippocampus, eyes, optic chiasm, and optic nerves. The [40°, 45°] tilt angle also showed significantly lower Dmax for brainstem and cochleas, as well as a lower Dmean for lens. In the [40°,45°] tilt angle for HA-WBRT, TOMO showed superior performance over VMAT for the PTV. TOMO achieved lower Dmax for brainstem, cochleas, optic nerves, and optic chiasm, as well as a lower Dmean for hippocampus. Furthermore, a significant correlation was found between delivery time and the PTV projection length in the sagittal plane.

Conclusion: The TOMO plan utilizing a tilt angle range of [40°, 45°] demonstrated superior PTV conformity and uniformity, along with enhanced OARs sparing. Furthermore, it exhibited a dosimetric advantage over VMAT for PTV and most OARs at the same angle range.

Keywords: dosimetry; efficacy; hippocampus; radiotherapy; tomotherapy.

PubMed Disclaimer

Conflict of interest statement

Declaration of conflicting interestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1.
Figure 1.
The representative CT simulated images depicted in panels (a) through (e) correspond to the following head tilt angle groups, respectively: (a) 5°, (b) 15°, (c) 25°, (d) 35°, and (e) 45°.
Figure 2.
Figure 2.
The comparison of (a) PTV conformity index, (b) PTV homogeneity index, (c) PTV D2cc, (d) PTV D98%, and (e) PTV mean dose among five groups for TOMO. Note: Bold values indicate significance at P < 0.05.
Figure 3.
Figure 3.
Comparison of the Dmax and Dmean of hippocampus for TOMO plans in various angles ((a) the Dmax of hippocampus, (b) the Dmean of hippocampus). Note: Bold values indicate significance at P < 0.05.
Figure 4.
Figure 4.
An illustration showcasing the dose distribution in the sagittal view for different tilt angles. The tilt angles of (a-e) were 5°, 15°, 25°, 35°, and 45°, respectively. The red arrows indicate regions with high dose (hot spots), while the blue arrows indicate regions with low dose (cold spots).
Figure 5.
Figure 5.
The comparison of (a) PTV conformity index, (b) PTV homogeneity index, (c) PTV D2cc, (d) PTV D98%, and (e) PTV Dmean for TOMO and VMAT plans. Note: Bold values indicate significance at P < 0.05.
Figure 6.
Figure 6.
Comparison of (a) delivery time, (b) PTV projection length in the sagittal plane, (c) hippocampus projection length in the sagittal plane, and (d) actual modulation factor among five groups. Note: Bold values indicate significance at P < 0.05.

Similar articles

References

    1. Mehta MP, Khuntia DJN. Current strategies in whole-brain radiation therapy for brain metastases. Neurosurgery. 2005;57(5):S4-33. - PubMed
    1. Saito EY, Viani GA, Ferrigno Ret al. Whole brain radiation therapy in management of brain metastasis: Results and prognostic factors. Radiat Oncol. 2006;1(1):1-7. - PMC - PubMed
    1. Gondi V, Tomé WA, Mehta MP. Why avoid the hippocampus? A comprehensive review. Radiother Oncol. 2010;97(3):370-376. - PMC - PubMed
    1. Gondi V, Hermann BP, Mehta MP, Tomé WA. Hippocampal dosimetry predicts neurocognitive function impairment after fractionated stereotactic radiotherapy for benign or low-grade adult brain tumors. Int J Radiat Oncol Biol Phys. 2012;83(4):e487-e493. - PMC - PubMed
    1. Gondi V, Tome WA, Marsh Jet al. Estimated risk of perihippocampal disease progression after hippocampal avoidance during whole-brain radiotherapy: Safety profile for RTOG 0933. Radiother Oncol. 2010;95(3):327-331. - PMC - PubMed

Publication types